IP Library Granted Patent US 7,971,996
Granted Patent B2
US 7,971,996 · App. 12/514,568 · Granted Jul 5, 2011

Multi-tint colored ophthalmic lenses for the short-sighted

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,971,996
App. No.
12/514,568
Granted
Jul 5, 2011
Kind
B2
Abstract

The present invention relates to an ophthalmic lens, having, on its surface, a colorless or yellow, central first zone and at least one peripheral second zone, selectively transmitting visible light having a wavelength of less than 570 nm.

Claims (10)

1. An ophthalmic lens, comprising, on its surface,

a first colorless or yellow-colored central zone, and

a second peripheral zone, selectively transmitting visible light having a wavelength of less than 570 nm,

wherein the peripheral zone is formed by a multitude of concentric annular zones, of different colors, each of the annular zones selectively transmitting visible light having a wavelength which is the shorter, the further the zone is from the central zone.

2. The ophthalmic lens according to claim 1 , which is a concave monofocal ophthalmic lens.

3. The ophthalmic lens according to claim 1 wherein the colorless or yellow-colored central zone is circular or oval in shape.

4. The ophthalmic lens according to claim 3 , wherein the colorless or yellow-colored central zone is centered on the optical centre of the lens.

5. The ophthalmic lens according to claim 3 , wherein the diameter or the largest dimension of the yellow-colored central zone is comprised between 5 and 35 mm.

6. The ophthalmic lens according to claim 1 wherein the peripheral zone exhibits, from its internal limit to its peripheral limit, the whole of the transmission spectrum of visible light of a wavelength comprised between 570 nm and 400 nm, the wavelength of the light transmitted progressively decreasing, preferably linearly, from the centre to the periphery of the zone.

7. Method for treating progressive myopia comprising the prescription, for a patient suffering from progressive myopia, of spectacles comprising at least one ophthalmic lens according to claim 1 .

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 6, 2018
From: ESSILOR INTERNATIONAL (COMPAGNIE GÉNÉRALE D'OPTIQUE)
To: ESSILOR INTERNATIONAL
Reel/Frame 045853/0275 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 11, 2010
From: DROBE, BJORN; GIRAUDET, GUILLAUME
To: ESSILOR INTERNATIONAL (COMPAGNIE GENERALE D'OPTIQUE)
Reel/Frame 023925/0223 →